Dr. Robert Whitfield uses brain imaging and genetic testing to investigate breast implant illness. Brain scans show changes in BII patients, and functional genomics analysis through The DNA Company reveals what Whitfield calls the most significant piece of understanding the condition.
The thing that most impressed me to have you on the show now is the fact that you're doing brain scans of people. And okay, brain scans with breast implant illness. Oh look, you are having changes. And then you're also doing the genetic testing. You're using the DNA Company, which is also really, really cool because guys, Cash has been on and other members of the team like Dr. Mansour, I think 4 or 5 times on the show because they're doing such cutting-edge DNA work. And to find that here we have a top expert in breast implant illness who's going to the DNA company, and yes guys, I should disclose I'm an investor and an advisor in the company. But you're doing that, I had no idea you were doing that until I sat down in your office. I'm like, you're using Who? All right. So what are you finding on the DNA side with breast implants? 'Cause I think this is interesting.
You know that, um, we talked a little bit about the urine marker and inflammation, so that was a big puzzle piece. But the biggest puzzle piece has been functional genomics from Dr. Mansour's group, and Kashif has been great. I mean, so helpful to us.
